Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgical rates in ulcerative colitis: have we made a difference?
Slattery E, Keegan D, Hyland J, Mulcahy H, O'Donoghue D. Slattery E, et al. Scand J Gastroenterol. 2011 Jan;46(1):122-3. doi: 10.3109/00365521.2010.516451. Epub 2010 Sep 1. Scand J Gastroenterol. 2011. PMID: 20809770 No abstract available.
Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease.
Judge C, McGettigan N, Ryan T, Hazel K, Singh P, Parihar V, Stack R, O'Connor A, Dunne C, Cullen G, Egan L, Harewood G, MacCarthy F, McKiernan S, Mulcahy H, Murray F, Patchett S, Sheridan J, Cheriyan D, Farrell R, Keohane J, Kelly O, McNamara D, Ryan B, O'Morain C, Sengupta S, O'Toole A, Buckley M, McCarthy J, Doherty G, Kevans D, Slattery E. Judge C, et al. Among authors: slattery e. Scand J Gastroenterol. 2020 Jul;55(7):786-794. doi: 10.1080/00365521.2020.1779340. Epub 2020 Jun 16. Scand J Gastroenterol. 2020. PMID: 32544012
Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis.
O'Connell J, Rowan C, Stack R, Harkin G, Parihar V, Chan G, Breslin N, Cullen G, Dunne C, Egan L, Harewood G, Leyden J, MacCarthy F, MacMathuna P, Mahmud N, McKiernan S, McNamara D, Mulcahy H, Murray F, O'Connor A, O'Toole A, Patchett S, Ryan B, Sheridan J, Slattery E, Doherty G, Kevans D. O'Connell J, et al. Among authors: slattery e. Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1019-1026. doi: 10.1097/MEG.0000000000001177. Eur J Gastroenterol Hepatol. 2018. PMID: 29878945
Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction.
Gibson DJ, Doherty J, McNally M, Campion J, Keegan D, Keogh A, Kennedy U, Byrne K, Egan LJ, McKiernan S, MacCarthy F, Sengupta S, Sheridan J, Mulcahy HE, Cullen G, Slattery E, Kevans D, Doherty GA. Gibson DJ, et al. Among authors: slattery e. Frontline Gastroenterol. 2019 Dec 13;11(6):441-447. doi: 10.1136/flgastro-2019-101335. eCollection 2020 Oct. Frontline Gastroenterol. 2019. PMID: 33104766 Free PMC article.
Cigarette smoking in Crohn's disease: can we do more?
Slattery E, Mitchell P, Mulcahy HE. Slattery E, et al. J Crohns Colitis. 2011 Oct;5(5):505. doi: 10.1016/j.crohns.2011.06.003. Epub 2011 Jul 13. J Crohns Colitis. 2011. PMID: 21939931 No abstract available.
Intravenous proton pump inhibitor use in hospital practice.
Slattery E, Theyventhiran R, Cullen G, Kennedy F, Ridge C, Nolan K, Kidney R, O'Donoghue DP, Mulcahy HE. Slattery E, et al. Eur J Gastroenterol Hepatol. 2007 Jun;19(6):461-4. doi: 10.1097/MEG.0b013e32810fd88a. Eur J Gastroenterol Hepatol. 2007. PMID: 17489055
90 results